December 1, 2021
RegMed Investors’ (RMi) closing bell: snap, crackle and drop
November 30, 2021
RegMed Investors’ (RMi) closing bell: a sector positive close to close the month
November 29, 2021
RegMed Investors’ (RMi) closing bell: Monday wasn’t quite the cell and gene therapy sector opportunity as I had questioned, what was sustainable?
November 26, 2021
RegMed Investors’ (RMi) closing bell: “Nu” or “Omicron” Covid variant fears explode the sector
November 24, 2021
RegMed Investors’ (RMi) closing bell: the week is almost over – celebrate Thanksgiving, forget markets; dig into the stuffing
November 23, 2021
RegMed Investors’ (RMi) closing bell: the afternoon sprung the cell and gene therapy sector to life
November 20, 2021
RegMed Investors’ (RMi) closing bell: Friday’s diving is more than a watersport
November 18, 2021
RegMed Investors’ (RMi) closing bell: sector dives even deeper
November 17, 2021
RegMed Investors’ (RMi) closing bell: sentiment’s headwinds obliterate sector’s share pricing
November 16, 2021
RegMed Investors’ (RMi) closing bell: wham-bam and a no thank you
November 15, 2021
RegMed Investors’ (RMi) closing bell: sector declines - it’s not transitory, infamous current terms
November 12, 2021
RegMed Investors’ (RMi) closing bell: gravity is more than a force, it’s a sector disorder
November 11, 2021
RegMed Investors’ (RMi) closing bell: from an extreme downside to a barely downslide
November 10, 2021
RegMed Investors’ (RMi) closing bell: yet another pull-back that cut to the bone as the sector bleeds-out
November 9, 2021
RegMed Investors’ (RMi) closing bell: sector takes yet another dive
November 8, 2021
RegMed Investors’ (RMi) closing bell: the sector faded even as small-cap stocks led on the upside and held near their highs
November 6, 2021
RegMed Investors’ (RMi) closing bell: bag and tag ‘em, as LPS (loss-per-share) earnings define the week’s share pricing endings
November 4, 2021
RegMed Investors’ (RMi) closing bell: not quite wrong and almost totally correct
November 3, 2021
RegMed Investors’ (RMi) closing bell: markets and sector, the big casino
November 2, 2021
RegMed Investors’ (RMi) closing bell: you say what, I say why
November 1, 2021
RegMed Investors’ (RMi) closing bell: waiting for the earnings ramp-up
October 29, 2021
RegMed Investors’ (RMi) closing bell: it was a head to the exit Friday
October 28, 2021
RegMed Investors’ (RMi) closing bell: a good session to sell into strength
October 27, 2021
RegMed Investors’ (RMi) closing bell: the market and sector symbolize a game of “chutes and ladders” of ups and downs
7 hours 29 min ago
RegMed Investors’ (RMi) pre-open: CPI headwinds and jobless headlights
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.